(Q57494821)
Statements
HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control (English)
0 references
1 September 2018
0 references
13
0 references
208-219
0 references
1 reference
scholarly article by Chen Zhao et al published 1 September 2018 in Molecular therapy. Nucleic acids